Aurobindo Pharma Limited
AUROPHARMA
Classifica tra le azioni
#2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Prezzo delle azioni
$17.34
Capitalizzazione di mercato
$9.98B
Variazione (1 giorno)
-3.08%
Variazione (1 anno)
38.71%
Paese
IN
Scambia Aurobindo Pharma Limited (AUROPHARMA)
Categoria
Healthcare
Rapporto P/S per Aurobindo Pharma Limited (AUROPHARMA)
Rapporto P/S al October 2026 TTM: 2.77
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Aurobindo Pharma Limited, il rapporto P/S attuale (TTM) è 2.77. Alla fine del 2024, era pari a 2.25.
Storico del rapporto P/S per Aurobindo Pharma Limited da 2004 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 2.77 | 33.31% |
| 2025 | 2.08 | -7.36% |
| 2024 | 2.25 | 82.40% |
| 2023 | 1.23 | -26.44% |
| 2022 | 1.68 | -20.27% |
| 2021 | 2.10 | 97.49% |
| 2020 | 1.06 | -55.13% |
| 2019 | 2.37 | 10.73% |
| 2018 | 2.14 | -20.47% |
| 2017 | 2.69 | -15.48% |
| 2016 | 3.19 | 7.66% |
| 2015 | 2.96 | 59.79% |
| 2014 | 1.85 | 142.25% |
| 2013 | 0.77 | 0.21% |
| 2012 | 0.76 | -40.71% |
| 2011 | 1.29 | -11.40% |
| 2010 | 1.45 | 342.21% |
| 2009 | 0.33 | -48.77% |
| 2008 | 0.64 | -62.35% |
| 2007 | 1.70 | -24.28% |
| 2006 | 2.25 | 103.16% |
| 2005 | 1.11 | -7.07% |
| 2004 | 1.19 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 154.53% |
IN
|
